Search results
What Are Hives (Urticaria)?
Health via Yahoo News· 1 year agoMedically reviewed by William Truswell, MD Hives (urticaria) is an inflammatory skin condition that causes bumps, or wheals, to form on the skin....
Acupuncture could help relieve chronic hives, Chinese study finds
United Press International via Yahoo News· 7 months agoAcupuncture may offer limited relief to patients with chronic hives, a new Chinese study indicates....
Pharma Stock Roundup: LLY, BAYRY Post Q2 Results, NVO's Wegovy Cuts Heart Attack Risk
Zacks via Yahoo Finance· 10 months agoThis week, Eli Lilly LLY, Bayer BAYRY and Novo Nordisk NVO announced second-quarter earnings. Novo...
Novartis reports Phase III data for trials of remibrutinib to treat CSU
Clinical Trials Arena via Yahoo Finance· 3 weeks agoNovartis has released new data from two Phase III clinical trials confirming the sustained efficacy...
Celldex Stock Rockets 28% On A Promising New Hives Treatment
Investor's Business Daily· 4 months agoCelldex Therapeutics unveiled promising results from a treatment for chronic hives on Monday. The...
Celldex’s reinvention advances with inflammatory disease drug data
BioPharma Dive via Yahoo Finance· 8 months agoDive Brief: Celldex Therapeutics shares rose in value by as much as 29% Monday morning following the...
Novartis (NVS) Reports Positive Long-Term Data on CSU Drug
Zacks via Yahoo Finance· 3 weeks agoNovartis NVS announced new long-term efficacy and safety data from the late-stage studies REMIX-1...
Celldex Makes A Bullish Move As It Looks To Take On Regeneron, Sanofi
Investor's Business Daily· 8 months agoCelldex Therapeutics could rival a key Regeneron Pharmaceuticals drug, an analyst said Monday as...
Jasper (JSPR) Up on FDA Nod to Begin Early-Stage Urticaria Study
Zacks via Yahoo Finance· 8 months agoJasper (JSPR) announces the FDA clearance to begin the clinical study of briquilimab for chronic...
Celldex (CLDX) Down on Interim Data From Phase Ib Study in CSU
Zacks via Yahoo Finance· 2 years agoCelldex (CLDX) posts interim data from the phase Ib study evaluating barzolvolimab in patients with...
